Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Heartburn & Stomach Medication Recalls

Recalls of acid reducers and stomach drugs - the class behind the ranitidine (Zantac) nitrosamine recalls.

211 recalls in this category, newest first.

Class II · Moderate risk

Ondansetron HCL

cGMP deviations: Temperature abuse

Terminated Temperature excursion Mckesson Medical-Surgical Inc. Corporate Office NDC 65862-188-30 D-1103-2022
Class II · Moderate risk

Esomeprazole Magnesium Delayed-Release Capsules

Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.

Terminated Impurity / degradation Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 42292-010-16 D-0861-2022
Class II · Moderate risk

Esomeprazole Magnesium Delayed-Release Capsules

Failed Impurities/Degradation Specifications: OOS result was obtained for Any Other Individual Impurity at the 12M room temperature time point.

Terminated Impurity / degradation Mylan Institutional, Inc. (d.b.a. UDL Laboratories) NDC 42292-009-16 D-0860-2022
Class II · Moderate risk

Omeprazole Delayed-Release Capsules

CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.

Terminated cGMP deviation Dr. Reddy's Laboratories, Inc. NDC 70000-0232-1 D-0026-2022
Class II · Moderate risk

Omeprazole Delayed Release Capsules

Failed Impurities/Degradation Specifications: Out of Specification results obtained for unknown impurities during stability testing by manufacturer

Terminated Impurity / degradation Golden State Medical Supply Inc. NDC 51407-129-10 D-0312-2021
Class II · Moderate risk

Omeprazole Delayed-Release Capsules

Failed Impurities/Degradation Specifications: Out-of-Specification results obtained for unknown impurities during stability testing.

Terminated Impurity / degradation Breckenridge Pharmaceutical, Inc NDC 51991-643-10 D-0308-2021
Class II · Moderate risk

Famotidine Tablets USP 40mg

Presence of foreign tablets/capsules: Famotidine 20mg and ibuprofen 400mg tablets were found in a lot of famotidine 40mg.

Terminated Particulate / foreign matter Aurobindo Pharma USA Inc. NDC 65862-860-99 D-0290-2021
Class III · Low risk

Famotidine Injection

TEMPERATURE ABUSE: Complaint received from customer that product was received in a non-refrigerated state.

Terminated Temperature excursion HF Acquisition Co. LLC NDC 63323-739-12 D-1392-2020
Class II · Moderate risk

Nizatidine Oral Solution

CGMP Deviations: potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.

Terminated Nitrosamine impurity Amneal Pharmaceuticals of New York, LLC NDC 60846-301-15 D-1253-2020
Class II · Moderate risk

Ranitidine 300 mg

CGMP Deviations: Presence of NDMA impurity detected in product.

Terminated Nitrosamine impurity Direct Rx NDC 61919-455-30 D-0017-2021
Class II · Moderate risk

Ranitidine 150 mg

CGMP Deviations: Presence of NDMA impurity detected in product.

Terminated Nitrosamine impurity Direct Rx NDC 61919-339-60 D-0016-2021
Class II · Moderate risk

ranitidine hydrochloride

CGMP Deviations: Received notice from supplier of potential -Nitrosodimethylamine (NDMA) amounts above established levels.

Terminated Nitrosamine impurity PD-Rx Pharmaceuticals, Inc. NDC 43063-844-14 D-0826-2020